Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01873014
Recruitment Status : Unknown
Verified May 2012 by Tianjin Medical University Cancer Institute and Hospital.
Recruitment status was:  Active, not recruiting
First Posted : June 7, 2013
Last Update Posted : February 17, 2016
Sponsor:
Information provided by (Responsible Party):
Tianjin Medical University Cancer Institute and Hospital

Brief Summary:
safe study of Chinese Herbs to Treat Thyroid Diseases With Different Iodine

Condition or disease Intervention/treatment Phase
Thyroid Diseases Drug: chinese herbs-I Drug: chinese herbs-II Phase 1 Phase 2

Detailed Description:
Based on the previous studies, the research choose the patients with different iodine intake,and improve our original Chinese Herbs thyroid III formula, in order to provide the patients the best individual treatment plan.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 400 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: the Effect of Chinese Herbs to Treat Thyroid Diseases With Different Iodine Intake
Study Start Date : June 2012
Estimated Primary Completion Date : October 2016
Estimated Study Completion Date : December 2016

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Thyroid Diseases
Drug Information available for: Iodine

Arm Intervention/treatment
Experimental: high Iodine intake Drug: chinese herbs-I
two agent per day, twice a day

Active Comparator: low Iodine intake Drug: chinese herbs-II
two agent per day, twice a day




Primary Outcome Measures :
  1. diameter,number of the tumor [ Time Frame: 3 months ]


Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 70 Years   (Adult, Older Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • patient with thyroid diseases

Exclusion Criteria:

  • not meet the diagnostic criteria,women with pregnancy or lactation ,drug allergy ,need surgery

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01873014


Sponsors and Collaborators
Tianjin Medical University Cancer Institute and Hospital
Investigators
Layout table for investigator information
Study Director: yu yang, doctor doctor

Layout table for additonal information
Responsible Party: Tianjin Medical University Cancer Institute and Hospital
ClinicalTrials.gov Identifier: NCT01873014     History of Changes
Other Study ID Numbers: head2012neck
First Posted: June 7, 2013    Key Record Dates
Last Update Posted: February 17, 2016
Last Verified: May 2012

Additional relevant MeSH terms:
Layout table for MeSH terms
Thyroid Diseases
Endocrine System Diseases
Iodine
Anti-Infective Agents, Local
Anti-Infective Agents
Trace Elements
Micronutrients
Nutrients
Growth Substances
Physiological Effects of Drugs